Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Structured summary of systematic reviews
JournalHTA Database
Year 2013
RECORD STATUS: This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. CITATION: Ward S, Pilgrim H, Hind D. Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal. Health Technology Assessment 2009; 13 (Suppl 1 Article 1): 1-6
Epistemonikos ID: d2aa25b3795b309ffd86734fc4d6bb314a38cf7c
First added on: Feb 06, 2015